528 Intratumoural treatment with LTX-, an oncolytic peptide immunotherapy, in patients with advanced metastatic disease induces CD8 effector cells and regression in some injected tumours

Authors :: James Spicer
Jean-François Baurain
A. Saunders
Jalal Vakili
O. Rekdal
Philippe Aftimos
B. Nicolaisen
F. Marjuadi
W.M. Olsen
M. Laruelle
P. Brunsvig
Ahmad Awada
Philippe Barthélémy
S. Deva
Source :: European Journal of Cancer. 51:S113
Publication Year :: 2015
Publisher :: Elsevier BV, 2015.

Subjects :: chemistry.chemical_classification
Cancer Research
business.industry
Effector
medicine.medical_treatment
Peptide
Disease
Immunotherapy
Oncolytic virus
Oncology
chemistry
Cancer research
Medicine
In patient
business
CD8

Full Text Access

Tools